<ENAMEX TYPE="ORGANIZATION">Devon Group Inc.</ENAMEX> said it bought back nearly 3.3 million common shares at $15 each in a private transaction with three of the company's founding shareholders.
The graphic-arts company said it bought 2,216,739 shares held by <ENAMEX TYPE="ORGANIZATION">Citicorp Venture Capital Ltd.</ENAMEX> and 671,995 shares held by <ENAMEX TYPE="ORGANIZATION">Rhode Island Hospital</ENAMEX> as trustee for the <ENAMEX TYPE="ORGANIZATION">Textron Collective Employee Trust</ENAMEX>. <ENAMEX TYPE="PERSON">Devon</ENAMEX> also said it bought 410,400 shares from <ENAMEX TYPE="LOCATION">Marne Obernauer</ENAMEX>, former <ENAMEX TYPE="ORGANIZATION">Devon</ENAMEX> chairman, who continues to hold 410,400 shares, or 5.8% of the 7.1 million shares now outstanding.
The company said it decided to purchase the stock because ``of all the corporate opportunities we've looked at over these past many months, none seemed more promising than our own company.'' <ENAMEX TYPE="PERSON">Devon</ENAMEX> also said it could improve per-share earnings and at the same time cause no reduction in the stock that is publicly held, because none of the repurchased shares ever traded publicly.
<ENAMEX TYPE="PERSON">Devon</ENAMEX> said <ENAMEX TYPE="ORGANIZATION">Citicorp</ENAMEX> bought about 1.9 million warrants at 28.5 cents each to acquire <ENAMEX TYPE="ORGANIZATION">Devon</ENAMEX> shares at $32 each for the next 18 months. In over-the-counter trading Friday, <ENAMEX TYPE="ORGANIZATION">Devon</ENAMEX> closed at $18.25, up $1.25.
<ENAMEX TYPE="ORGANIZATION">Devon</ENAMEX> said <ENAMEX TYPE="PERSON">David F. Thomas</ENAMEX>, vice president of <ENAMEX TYPE="ORGANIZATION">Citicorp Venture Capital</ENAMEX>, resigned from <ENAMEX TYPE="LOCATION">Devon</ENAMEX>'s board, reducing the board to six members.
